Archives

img-01

Advertising and Promotion in Japan: Shonin Required

Given Japan’s conservative regulatory environment, it should come at no surprise that advertising and promotion of medical devices and pharmaceuticals in Japan is highly regulated and very restrictive. Without shonin, or “approval” of a product, advertising the name, manufacturing process, indications, effects,... Read More

img-01

Japan’s In Country Caretaker (ICC) System: An Overview

Regulations in Japan are rapidly changing and the information in this news brief from 2001 may provide outdated information on Japan’s current medical industry. For updated and in-depth information on Japan’s in-country caretaker and distributor search process, please visit our Japan Distributor Search page. A... Read More

img-01

2000 Update on Japan’s Medical Device Market

This article is a review of Japan's transforming medical device market. Topics include Japan's medical community, the economy, deregulation issues, pricing and reimbursement, the eldercare market, market entry strategies, and distribution strategies. Figures and statistics are included as guides for each topic.... Read More

img-01

Japan Medical Device Market 2000

Japan's medical device market is worth about $23.4 billion and is the second largest in the world, after the U.S. This article goes over some of the key factors in Japan's medical device market, including product registration, reimbursement approval and market entry... Read More

img-01

Japan: 1999 Year-End Medical Device Update

Despite the difficulties foreign companies sometimes face when entering the Japanese medical device market, strong demand for more technologically advanced products and sophisticated medical treatment has opened up the market more to manufacturers who can meet this demand. The Japanese government is... Read More

img-01

Entering the Japanese Medical Device Market

Japan's recent economic recession has not slowed the great demand for technologically innovative products that are flooding the Western medical markets. The country's aging population and the government's efforts at deregulating the distribution process are some of the main factors pushing Japan's... Read More

img-01

Japan Pharmaceutical Update

Recent deregulation reforms within the Japanese pharmaceutical market have been applauded by international pharmaceutical companies and associations alike. Major reform efforts include: withdrawal of the reference pricing system, speeding up the approval process for new drugs, more acceptance of foreign clinical data,... Read More